An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Abstract

BackgroundThe Bergamo province, which is extensively affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic, is a natural observatory of virus manifestations in the general population. In the past month we recorded an outbreak of Kawasaki disease; we aimed to evaluate incidence and features of patients with Kawasaki-like disease diagnosed during the SARS-CoV-2 epidemic. MethodsAll patients diagnosed with a Kawasaki-like disease at our centre in the past 5 years were divided according to symptomatic presentation before (group 1) or after (group 2) the beginning of the SARS-CoV-2 epidemic. Kawasakilike presentations were managed as Kawasaki disease according to the American Heart Association indications. Kawasaki disease shock syndrome (KDSS) was defined by presence of circulatory dysfunction, and macrophage activation syndrome (MAS) by the Paediatric Rheumatology International Trials Organisation criteria. Current or previous infection was sought by reverse-transcriptase quantitative PCR in nasopharyngeal and oropharyngeal swabs, and by serological qualitative test detecting SARS-CoV-2 IgM and IgG, respectively. Findings Group 1 comprised 19 patients (seven boys, 12 girls; aged 3•0 years [SD 2•5]) diagnosed between Jan 1, 2015, and Feb 17, 2020. Group 2 included ten patients (seven boys, three girls; aged 7•5 years [SD 3•5]) diagnosed between Feb 18 and April 20, 2020; eight of ten were positive for IgG or IgM, or both. The two groups differed in disease incidence (group 1 vs group 2, 0•3 vs ten per month), mean age (3•0 vs 7•5 years), cardiac involvement (two of 19 vs six of ten), KDSS (zero of 19 vs five of ten), MAS (zero of 19 vs five of ten), and need for adjunctive steroid treatment (three of 19 vs eight of ten; all p<0•01). InterpretationIn the past month we found a 30-fold increased incidence of Kawasaki-like disease. Children diagnosed after the SARS-CoV-2 epidemic began showed evidence of immune response to the virus, were older, had a higher rate of cardiac involvement, and features of MAS. The SARS-CoV-2 epidemic was associated with high incidence of a severe form of Kawasaki disease. A similar outbreak of Kawasaki-like disease is expected in countries involved in the SARS-CoV-2 epidemic.Funding None.

Clinical Characteristics of Pediatric Inflammatory Multisystem Syndrome Associated With COVID-19

“…Corticosteroids were prescribed for two patients with resistant Kawasaki disease with giant aneurism and multiorgan failure. As with other studies, the prognosis of most patients was good (4,5,7,13,15). Almost all our patients discharged without complication, except one case with giant aneurysms.…”

Epidemiological and clinical characteristics of COVID-19 in Indian children in the initial phase of the pandemic: A cross-sectional study

“…35 Recently an alarming rise in the number of Pediatric and adolescent Kawasaki Disease and a multisystemic hyper-in ammatory syndrome associated with COVID-19 requiring admission to intensive care units have been reported in Europe as well as North America as the pandemic has progressed. 36,37,38 An acute onset illness accompanied by a hyperin ammatory syndrome, leading to multi-organ failure and shock has been described. Initial hypotheses suggest association with COVID-19 either as a direct manifestation or an antibody positive post-infectious immune mediated response based on initial laboratory testing.…”

COVID-19 and Children With Down Syndrome: is There Any Real Reason to Worry? Case Report

“…At the beginning of this pandemic, children seemed to be relatively spared; however, later reports from various centres described a potentially COVID-19-related severe multisystem in ammatory syndrome in children and young adults [10,11].…”